Clinical Scorecard: PT vs CBT for Chronic Low Back Pain
At a Glance
Category
Detail
Condition
Chronic low back pain
Key Mechanisms
Physical therapy (PT) and cognitive behavioral therapy (CBT) as nonpharmacologic interventions targeting function and pain management
Target Population
Adults with chronic low back pain
Care Setting
Multisite US health systems with outpatient physical therapy and mental health services
Key Highlights
PT showed small improvements in function compared with CBT but no difference in pain intensity at 10, 26, and 52 weeks.
Response rates were higher with PT (25%) than CBT (14%), with PT associated with fewer spinal injections.
Among nonresponders, switching therapies or mindfulness-based treatment showed no significant differences in outcomes.
Guideline-Based Recommendations
Diagnosis
Identify chronic low back pain patients with less than 50% functional improvement as nonresponders.
Management
Consider physical therapy as first-line treatment for chronic low back pain.
For nonresponders, second-stage treatments including switching therapies or mindfulness-based interventions may be considered, though no differences in outcomes were observed.
Monitoring & Follow-up
Assess functional improvement using the Oswestry Disability Index and PROMIS domains.
Monitor pain intensity on a 0 to 10 scale.
Track treatment adherence via session attendance.
Risks
Serious adverse events occurred in 5% of patients, including back surgeries, with similar rates across PT and CBT groups.
Patient & Prescribing Data
749 adult participants with chronic low back pain enrolled across three US health systems.
PT resulted in greater functional improvement and fewer spinal injections compared to CBT; no difference in pain intensity; adherence and engagement varied.
Clinical Best Practices
Initiate treatment with physical therapy for chronic low back pain patients.
Use functional improvement metrics to guide treatment adjustments.
Consider mindfulness or therapy switching for nonresponders, recognizing limited evidence for superiority.
Deliver interventions flexibly to accommodate patient needs and provider availability.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
